Hasan Yazici

Summary

Publications

  1. ncbi Behçet's syndrome: an update
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, Cerrrahpa Medical Faculty, University of Istanbul, Aksarary 34303, Istanbul, Turkey
    Curr Rheumatol Rep 5:195-9. 2003
  2. ncbi Diagnostic versus classification criteria - a continuum
    Hasan Yazici
    Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 67:206-8. 2009
  3. ncbi The lumps and bumps of Behçet's syndrome
    H Yazici
    Division of Rheumatology, Dept. of Medecine, Cerrahpasa Medical Faculty, University of Istanbul, Aksaray, Istanbul, 34303 Turkey
    Autoimmun Rev 3:S53-4. 2004
  4. ncbi Mortality in Behçet's syndrome
    H Yazici
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Clin Exp Rheumatol 26:S138-40. 2008
  5. ncbi Behçet's syndrome: disease manifestations, management, and advances in treatment
    Hasan Yazici
    Department of Medicine and the Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Nat Clin Pract Rheumatol 3:148-55. 2007
  6. ncbi What is wrong with what is said?
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 66:140-2. 2008
  7. ncbi Behçet disease
    H Yazici
    Division of Rheumatology, Department of Medicine Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Curr Opin Rheumatol 13:18-22. 2001
  8. ncbi Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial
    Vedat Hamuryudan
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Aksaray, 34365, Istanbul, Turkey
    Rheumatology (Oxford) 49:173-7. 2010
  9. ncbi Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients
    Emire Seyahi
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Medicine (Baltimore) 91:35-48. 2012
  10. ncbi Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study
    Melike Melikoglu
    , Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Rheumatol 32:98-105. 2005

Collaborators

Detail Information

Publications63

  1. ncbi Behçet's syndrome: an update
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, Cerrrahpa Medical Faculty, University of Istanbul, Aksarary 34303, Istanbul, Turkey
    Curr Rheumatol Rep 5:195-9. 2003
    ..However, the disease burns out in many cases. Clinicians are getting better at management, and have better understanding of the old drugs, such as colchicine, and have new and potent drugs like tumor necrosis factor-alpha inhibitors...
  2. ncbi Diagnostic versus classification criteria - a continuum
    Hasan Yazici
    Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 67:206-8. 2009
    ..The main element that makes a set of criteria diagnostic is the pretest odds. We should question our current practice of making universal disease criteria and perhaps design criteria tailored to subspecialties...
  3. ncbi The lumps and bumps of Behçet's syndrome
    H Yazici
    Division of Rheumatology, Dept. of Medecine, Cerrahpasa Medical Faculty, University of Istanbul, Aksaray, Istanbul, 34303 Turkey
    Autoimmun Rev 3:S53-4. 2004
  4. ncbi Mortality in Behçet's syndrome
    H Yazici
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Clin Exp Rheumatol 26:S138-40. 2008
    ..However, this is not due to arterial involvement but due to venous disease of the lower extremities. Recently there has been a substantial decrease in mortality due to PAA thanks to prompt disease recognition and treatment...
  5. ncbi Behçet's syndrome: disease manifestations, management, and advances in treatment
    Hasan Yazici
    Department of Medicine and the Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Nat Clin Pract Rheumatol 3:148-55. 2007
    ..Although treatment of skin-mucosa manifestations, eye disease and pulmonary artery aneurysms has improved significantly in the past decades, the treatment of CNS lesions and thrombophilia are still problematic...
  6. ncbi What is wrong with what is said?
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 66:140-2. 2008
    ..This interactive educational exercise is an attempt to highlight these flaws in short scenarios...
  7. ncbi Behçet disease
    H Yazici
    Division of Rheumatology, Department of Medicine Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Curr Opin Rheumatol 13:18-22. 2001
    ..The heightened inflammatory response of BD patients to simple trauma may lead to postoperative complications, but should not be regarded as a contraindication to surgery...
  8. ncbi Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial
    Vedat Hamuryudan
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Aksaray, 34365, Istanbul, Turkey
    Rheumatology (Oxford) 49:173-7. 2010
    ..To assess the influence of being free of major organ involvement during the early years of the disease on the prognosis of men with Behçet's syndrome (BS)...
  9. ncbi Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients
    Emire Seyahi
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Medicine (Baltimore) 91:35-48. 2012
    ..Corticosteroids and immunosuppressive agents are the mainstays of treatment; however, refractory cases may require embolization, lobectomy, cavitectomy, and decortication...
  10. ncbi Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study
    Melike Melikoglu
    , Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Rheumatol 32:98-105. 2005
    ..17, p = 0.0002, respectively). CONCLUSION: Etanercept did not affect the pathergy reaction and the cutaneous response to MSU crystals. However, the drug was effective in suppressing most of the mucocutaneous manifestations of BD...
  11. ncbi The papulopustular lesion/arthritis cluster of Behçet's syndrome also clusters in families
    Mehmet Karaca
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, Istanbul University, Turkey
    Rheumatology (Oxford) 51:1053-60. 2012
    ..To test this hypothesis, we compared the frequency of symptom clusters between familial (group F) and non-familial (group NF) cases of BS...
  12. ncbi Pulmonary artery aneurysms in Behçet syndrome
    Vedat Hamuryudan
    , Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Am J Med 117:867-70. 2004
  13. ncbi The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center
    Emire Kural-Seyahi
    , Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Medicine (Baltimore) 82:60-76. 2003
    ..There were no female patients with arterial aneurysms. Severely impaired vision did not always mean an eventual loss of useful vision, and those patients with a late onset of eye disease had a better visual prognosis...
  14. ncbi Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome
    Hasan Kilic
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Rheumatology (Oxford) 48:1388-91. 2009
    ..We investigated the efficacy and collected initial data on the safety of low-dose natural human IFN-alpha administered by the oral mucosal route in Behçet's syndrome (BS) in a placebo controlled, double blind study...
  15. ncbi Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease
    Hasan Tuzun
    Department of Cardiovascular Surgery, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Vasc Surg 55:157-63. 2012
    ....
  16. ncbi A twin study in Behçet's syndrome
    Seval Masatlioglu
    Division of Rheumatology, Haydarpaşa Numune Research and Education Hospital, Istanbul, Turkey
    Clin Exp Rheumatol 28:S62-6. 2010
    ..We sought the frequency of MZ and dizygotic (DZ) twin births in BS and compared it to a healthy population sample from the same geography. We also looked for the concordance rate among the MZ and DZ twins...
  17. ncbi The estimated pulmonary artery pressure can be elevated in Behçet's syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Respir Med 105:1739-47. 2011
    ....
  18. ncbi The unique features of vasculitis in Behçet's syndrome
    Melike Melikoglu
    Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Aksaray, Istanbul, Turkey
    Clin Rev Allergy Immunol 35:40-6. 2008
    ....
  19. ncbi Atherosclerosis in Behçet's Syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Semin Arthritis Rheum 38:1-12. 2008
    ..Thus, we evaluated the presence of subclinical atherosclerosis in a sizeable group of patients with BS both with major organ involvement and mucocutaneous disease along with diseased and healthy controls...
  20. ncbi Comparative study of adhesion molecule expression in nodular lesions of Behçet syndrome and other forms of panniculitis
    Cuyan Demirkesen
    Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Am J Clin Pathol 130:28-33. 2008
    ..0208). Because many lesions of BS were related to an enhanced inflammatory response, the lower percentage of ICAM-1 expression seems counterintuitive...
  21. ncbi Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
    Arthritis Rheum 58:1539-45. 2008
    ..The aim of this study was to test the hypothesis that enthesopathy is increased in this cluster, having features reminiscent of acne-associated arthritis...
  22. ncbi The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey
    Emire Seyahi
    Department of Medicine, University of Istanbul, Istanbul, Turkey
    Clin Exp Rheumatol 28:S67-75. 2010
    ..We also studied HLA-B51 and MEFV mutations among a group of healthy Armenians and a non-Armenian population...
  23. ncbi Headache in Behçet's syndrome
    Sabahattin Saip
    The Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Headache 45:911-9. 2005
    ..This form of headache is not specific for this disorder, but may be explained by a vascular headache triggered by the immunomediated disease activity in susceptible individuals...
  24. ncbi JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome
    M Cem Ar
    Division of Hematology, Department of Internal Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey
    Clin Appl Thromb Hemost 18:421-6. 2012
    ..Our data suggest that JAK2 (V617F) is not directly related to thrombosis in MPNs and in other thrombotic entities, such as BS...
  25. ncbi Treatment strategies for Behçet's disease
    Izzet Fresko
    Department of Rheumatology, Cerrahpasa Medical Faculty, Cerrahpasa Tip Fakultesi, Ic Hastaliklari ABD, 34300 Aksaray, Istanbul, Turkey
    Expert Opin Pharmacother 9:3211-9. 2008
    ..It is rare in the Western world but is frequent in the Middle and Far East...
  26. ncbi The management of Behçet's syndrome
    Emire Seyahi
    Division of Rheumatology, , University of Istanbul, Turkey
    Acta Reumatol Port 31:125-31. 2006
    ..The disease runs a more severe course among young males and the severity diminishes with age. This review describes the management of this disease, which should be individualized and varies according to site and gender...
  27. ncbi Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
    Arthritis Res Ther 14:R147. 2012
    ....
  28. ncbi Infliximab does not suppress the tuberculin skin test (purified protein derivative)
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Rheumatology Division and Haydarpasa Numune Hospital, Department of Internal Medicine, Istanbul, Turkey
    J Rheumatol 34:474-80. 2007
    ..We assessed whether infliximab, a strong inhibitor of inflammation, suppressed dermal induration, the outcome of this test. We also reassessed the booster phenomenon and the interobserver variability in tuberculin testing...
  29. ncbi Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers
    Melike Melikoglu
    Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    J Immunol 177:6415-21. 2006
    ....
  30. ncbi Behçet syndrome
    Sebahattin Yurdakul
    Division of Rheumatology, Department of Medicin, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Curr Opin Rheumatol 16:38-42. 2004
    ..For management, preliminary yet promising experience with the use of anti-tumor necrosis factor agents is being reported. SUMMARY When compared with 2 decades ago, we know considerably more and can do more about BS...
  31. ncbi Behçet's syndrome
    Sebahattin Yurdakul
    Department of Medicine, Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Best Pract Res Clin Rheumatol 22:793-809. 2008
    ....
  32. ncbi Thought barriers to understanding rheumatic diseases--Halstead R. Holman revisited
    Hasan Yazici
    Department of Medicine, Division of Rheumatology, Cerrahpasa School of Medicine, University of Istanbul, Istanbul, Turkey
    Bull NYU Hosp Jt Dis 68:143-6. 2010
    ..misuse of the controlled clinical trial. The popular inductive reasoning with the propensity to prove rather than to falsify one's self might be the common denominator in many of the barriers discussed...
  33. ncbi Behçet's Syndrome
    Gulen Hatemi
    Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Cerrahpasa, Istanbul 34089, Turkey
    Rheum Dis Clin North Am 39:245-61. 2013
    ..Being a serious health problem in endemic areas, BS also attracts global attention as a model to study inflammatory diseases of unknown cause...
  34. ncbi Behçet's syndrome and micro-organisms
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
    Best Pract Res Clin Rheumatol 25:389-406. 2011
    ..Moreover, basic research on both viruses and bacteria suggests that micro-organisms may be playing a role, possibly through heat shock proteins and T-cell hypersensitivity...
  35. ncbi An audit of Behcet's syndrome research: a 10-year survey
    Fehim Esen
    Cerrahpasa Medical Faculty and Division of Rheumatology, Istanbul University, Turkey
    J Rheumatol 38:99-103. 2011
    ..We reason that recognizing such methodological shortcomings will lead to better quality clinical and basic science articles...
  36. ncbi Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study
    Vedat Hamuryudan
    Behçet s Syndrome Research Center, Cerrahpaa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Isr Med Assoc J 4:928-30. 2002
    ..Eye involvement is the main cause of morbidity in Behçet's syndrome. The efficacy of the combined use of azathioprine and interferon alfa in treating this condition has not been studied...
  37. ncbi The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study
    M Cem Mat
    Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Int J Dermatol 45:554-6. 2006
    ..Although genital ulceration with or without scar formation is an important manifestation of Behçet's syndrome, formal data on the rate of genital scarring are lacking...
  38. ncbi Beware of registries for their biases
    Hasan Yazici
    Division of Rheumatology and Department of Medicine, Istanbul University, Istanbul, Turkey
    Bull NYU Hosp Jt Dis 70:95-8. 2012
    ..This is where the mortality in a mother population lessens the mortality in the registry that stems from this mother population simply because deaths in the former cannot be represented in the latter...
  39. ncbi Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis
    Recep Tunc
    Department of Rheumatology, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Rheumatol 29:2393-6. 2002
    ..To look for target organ associations in Turkish patients with Behçet's disease (BD)...
  40. ncbi Takayasu disease with prominent pulmonary artery involvement: confusion with pulmonary disease leading to delayed diagnosis
    Bilgehan Karadag
    Department of Cardiology, Cerrahpasa School of Medicine, Istanbul University, 34098, Istanbul, Turkey
    Mod Rheumatol 18:507-10. 2008
    ..The frequency of such a clinical form could be underestimated given the difficulties involved in its diagnosis and because its features are similar to those of pulmonary disease...
  41. ncbi Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma
    M Cem Ar
    Department of Internal Medicine, Division of Haematology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Ann Hematol 84:609-13. 2005
    ..LV in this patient was primarily considered to be the result of progressive cryoglobulinemia, which was closely associated with MM. She was successfully managed with thalidomide and dexamethasone...
  42. ncbi Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study
    F Moral
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 13:493-5. 1995
    ..05). There were also no differences in the mean numbers of acetaminophen tablets used or in the CRP and ESR levels between the two groups. We conclude that azapropazone is not effective in controlling the arthritis of Behçet's syndrome...
  43. ncbi Behçet's syndrome is not associated with vitiligo
    M Oran
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Clin Exp Rheumatol 26:S107-9. 2008
    ..Our informal observation was that vitiligo is also uncommon among BS patients. With this controlled and masked study we formally surveyed the presence of vitiligo among BS patients and suitable controls...
  44. ncbi Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease
    I Hatemi
    Division of Gastroenterology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Clin Exp Rheumatol 26:S91-5. 2008
    ....
  45. ncbi Behçet's disease: diagnostic and prognostic aspects of neurological involvement
    A Siva
    Department of Neurology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
    J Neurol 248:95-103. 2001
    ..Onset with headache or a diagnosis of VST is favorable. Two major neurological diagnoses in BD are NBS and VST. These are distinct in clinical, radiological, and prognostic aspects, hence suggesting a difference in pathogenesis...
  46. ncbi Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome
    C Demirkesen
    Department of Pathology, Division of Romatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Am J Clin Pathol 116:341-6. 2001
    ..Nodular lesions of Behçet syndrome are mainly neutrophilic vascular reactions with histologic features similar to NV but significantly differing from EN associated with other systemic diseases...
  47. ncbi A double-blind trial of colchicine in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, University of Istanbul, Turkey
    Arthritis Rheum 44:2686-92. 2001
    ..We reassessed the effect of colchicine in Behçet's syndrome in a study conducted among a larger group of patients for 2 years...
  48. ncbi The pustular skin lesions in Behcet's syndrome are not sterile
    G Hatemi
    Istanbul University, Cerrahpasa Medical School, Division of Rheumatology, Istanbul, Turkey
    Ann Rheum Dis 63:1450-2. 2004
    ..CONCLUSIONS: The pustular lesions of BS are not usually sterile. The microbiology of these lesions is different from ordinary acne. It remains to be determined whether the infection is secondary or has any pathogenic implications...
  49. ncbi Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome
    R Tunc
    Department of Internal Medicine, Division of Rheumatology, Meram School of Medicine, Selcuk University, Konya, Turkey
    Ann Rheum Dis 63:1693-4. 2004
    ..To examine the association between the type of central nervous system (CNS) involvement (parenchymal disease and cerebral venous thrombosis (CVT)) and extra-cranial large vessel events, mainly venous thrombosis, in Behcet's syndrome (BS)...
  50. ncbi A double-blind trial of depot corticosteroids in Behçet's syndrome
    C Mat
    Department of Dermatology, , Cerrahpasa Medical Faculty, Univerisity of Istanbul, Turkey
    Rheumatology (Oxford) 45:348-52. 2006
    ..0148) but not for males (P = 0.1). CONCLUSION: Low-dose depot corticosteroids did not have any beneficial effect on genital ulcers. However, it was useful in controlling erythema nodosum lesions, especially among the females...
  51. ncbi Fibrinolytic activity and d-dimer levels in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Istanbul, Turkey
    Clin Exp Rheumatol 23:S53-8. 2005
    ..We have studied tissue-type plasminogen activator (t-PA) and its inhibitor (PAI-1), and d-dimer levels in BS patients with and without thrombosis both in the acute and chronic phases along with suitable diseased and healthy controls...
  52. ncbi Intestinal permeability in Behçet's syndrome
    I Fresko
    Department of Rheumatology, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Ann Rheum Dis 60:65-6. 2001
    ..To measure the intestinal permeability in patients with Behçet's syndrome (BS) and to compare the results with those obtained from healthy and diseased controls...
  53. ncbi Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome
    L Tasli
    Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Clin Exp Rheumatol 24:S83-6. 2006
    ..CONCLUSIONS: In this pilot and open study Lactobacillus brevis CD2 lozenges seemed to be effective in controlling the OU of BS. Randomized, controlled trials with this seemingly innocuous agent are now needed...
  54. ncbi A cost analysis of Behcet's syndrome in Turkey
    N Sut
    Department of Biostatistics, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 46:678-82. 2007
    ..Behçet's syndrome (BS), a common chronic inflammatory disease in Turkey, results in considerable morbidity and increased mortality. We aimed to estimate its direct and indirect costs...
  55. ncbi Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome
    I Fresko
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Clin Exp Rheumatol 23:S67-70. 2005
    ..Increased as well as normal levels have been reported in Behçet's syndrome (BS). We reassessed the level of IgG and IgA ASCA antibodies in BS and in a group of diseased and healthy controls...
  56. ncbi Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 68:1528-34. 2009
    ....
  57. ncbi EULAR recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 67:1656-62. 2008
    ..To develop evidence-based European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease (BD) supplemented where necessary by expert opinion...
  58. ncbi A reappraisal of amyloidosis in Behçet's syndrome
    M Melikoglu
    Department of Rheumatology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 40:212-5. 2001
    ..To evaluate the clinical features and outcome of patients with Behçet's syndrome (BS) and amyloidosis and to assess the associated risk factors...
  59. ncbi Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease
    U Korman
    Department of Radiology, Cerrahpasa Medical Faculty, Istanbul University, 34300 Istanbul, Turkey
    Abdom Imaging 28:308-12. 2003
    ..The main EC finding in BD was ulceration mostly in the aphthous form. The EC findings in BD, even in longstanding cases, are usually mild when compared with those seen in CD...
  60. ncbi Behçet's syndrome: where do we stand?
    Hasan Yazici
    Am J Med 112:75-6. 2002
  61. ncbi EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
    Bernhard Hellmich
    Department of Rheumatology, University Hospital of Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Ann Rheum Dis 66:605-17. 2007
    ..To develop the European League Against Rheumatism (EULAR) recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis...
  62. ncbi Behçet's disease and other autoinflammatory conditions: what's in a name?
    Hasan Yazici
    Clin Exp Rheumatol 23:S1-2. 2005
  63. ncbi Use of statistical analysis in open extension studies
    Yusuf Yazici
    J Rheumatol 33:437; author reply 437-8. 2006